Physician profile
Michael L Bailey
NPI 1215931639
$528.57
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $20.30 · 2021: $42.72 · 2022: $74.81 · 2023: $179 · 2024: $69.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.95 | 2023 | Wegovy, Rybelsus, Ozempic |
| Avanos Medical | $62.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.07 | 2022-2023 | |
| Lilly USA, LLC | $45.53 | 2024 | Zepbound |
| Allergan, INC. | $35.55 | 2020-2022 | |
| Intuitive Surgical, INC. | $34.35 | 2019 | |
| Merz North America, INC. | $30.55 | 2019 | |
| Genentech USA, INC. | $26.37 | 2021-2022 | |
| Abbvie INC. | $24.17 | 2024 | |
| Si-Bone, INC. | $18.34 | 2021 | |
| Phadia US INC. | $16.79 | 2023 | Immunocap |
| Boston Scientific Corporation | $16.09 | 2022 | |
| Elevate Oral Care | $14.25 | 2019 | |
| Fisher & Paykel Healthcare INC | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.